🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marina Chiara Garassino

University of Chicago

ORCID: 0000-0002-3821-5598

Also affiliated with University of Chicago Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.109Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423
Top 72%
0.109DataRank
Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Papers

Driven by 18 papers — median percentile 28. Top paper: “Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer”.

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01308
N/A
7.3DataRank · unranked
1324 citations

Corinne Faivre‐Finn, Jhanelle E. Gray, David Vicente, David Planchard, Luis Paz‐Ares +20 more

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2020.12.015
N/A
6.9DataRank · unranked
471 citations

David Vicente, Takayasu Kurata, David Planchard, Luis Paz‐Ares, Johan Vansteenkiste +18 more

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet(2024)10.1016/s0140-6736(24)01756-2
N/A
3.7DataRank · unranked
262 citations

Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +91 more

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

New England Journal of Medicine(2018)10.1056/nejmoa1801005
N/A
1.3DataRank · unranked
6524 citations

Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis +34 more

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

Molecular Cancer(2024)10.1186/s12943-024-02014-x
N/A
0.975DataRank · unranked
43 citations

Miljenka Vuko, Jaime Rodriguez‐Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien +13 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420
N/A
0.787DataRank · unranked
189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7
N/A
0.769DataRank · unranked
168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Cancer Cell(2020)10.1016/j.ccell.2020.05.008
N/A
0.614DataRank · unranked
59 citations

Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini +12 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423
Top 72%
0.109DataRank
Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

The use of artificial intelligence with uncertainty estimation to predict lung cancer relapse from histopathology.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8549
N/A
0.104DataRank · unranked
1 citations

Sara Kochanny, Annie Zhu, Sagar Rakshit, Radhika Bansal, Melanie C. Bois +6 more

Deep learning discriminates thymic epithelial tumors’ histological subtypes using digital pathology

Annals of Oncology(2025)10.1016/j.annonc.2025.12.003
N/A
0DataRank · unranked
1 citations

Erica Pietroluongo, Anna Di Lello, Mirella Marino, Alexander McGeough, A. Esposito +8 more

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials

Cancer(2020)10.1002/cncr.33142
N/A
0DataRank · unranked
111 citations

Corey J. Langer, Luis Paz‐Ares, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino +8 more

At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0008
N/A
0DataRank · unranked
28 citations

Antoni Ribas, Marina Chiara Garassino

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Nature Communications(2022)10.1038/s41467-022-34025-x
N/A
0DataRank · unranked
125 citations

Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody +11 more

Deep learning generates synthetic cancer histology for explainability and education

npj Precision Oncology(2023)10.1038/s41698-023-00399-4
N/A
0DataRank · unranked
72 citations

Rachelle Wolk, Hanna M. Hieromnimon, Frederick M. Howard, Andrew Srisuwananukorn, Dmitry Karpeyev +18 more

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231198446
N/A
0DataRank · unranked
7 citations

Jacobi Hines, Valter Torri, Luca Porcu, Jessica Donington, Christine M. Bestvina +5 more

Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learning

EBioMedicine(2024)10.1016/j.ebiom.2024.105276
N/A
0DataRank · unranked
14 citations

James M. Dolezal, Emma Dyer, Sara Kochanny, Siddhi Ramesh, Frederick M. Howard +7 more

Delays in phases of care from identification to treatment of suspicious lung nodules

JTCVS Open(2025)10.1016/j.xjon.2025.01.006
N/A
0DataRank · unranked
1 citations

Rachel Nordgren, Aliya N. Husain, Aditya Juloori, Christine M. Bestvina, Rajat Thawani +10 more